Media Thread, page-8956

Interesting comments ......
and reminds me to point out that at this stage across all the treatment
trials IMU are involved in ( I think ) ....they are only allowed to have a crack at patients
who are pretty much at the end of the road and not responding to other treatments .

In other words ...who knows what damage might have been caused by previous efforts ,
who knows how advanced a particular cancer might have gone / or general damage to the heath of the individual might have been sustained ....by any treatment not working and the continued advancement of the disease.

( interesting to speculate what might have been the result of an IMU trial early on in a patients journey ........ )

I mean its bit like trying to fix a car when the engines blown ...... rather than tweaking the timing and settings and doing the maintenance early on.

( ie getting in early before the damage is done )

Whether the person you refer to has been on the c33 trial or not ...naturally we don't exactly know .....

With regards to these IMU trials generally , and successes noted ( along with zero to minimal toxicity ) one wonders at what point would someone be able say ....... " I want what he's having thanks"

A very simplistic view perhaps ....but if a new treatment gets the thumbs up and is effective , without toxicity & side effects one would imagine there would be huge pressure from many quarters to go the next level ....... and " release the Craken"

Thats where the imagination and vision of the financial markets might get a bit excited as well